Format

Send to

Choose Destination
Vaccine. 2017 Dec 4;35(48 Pt A):6518-6528. doi: 10.1016/j.vaccine.2017.01.040.

Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.

Author information

1
Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases and Global Health Center, Cincinnati, OH, USA. Electronic address: contact@brightoncollaboration.org.
2
Baylor College of Medicine, Department of Pediatrics and Molecular Virology and Microbiology, Houston, TX, USA.
3
ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - University of Barcelona, Barcelona, Spain.
4
Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
5
Fetal Medicine Unit, St George's Hospital, University of London, UK.
6
Fetal Medicine Unit, University Hospital of Leicester, UK.
7
Office of Clinical Research Resources, NIAID/NIH, Rockville, MD, USA.
8
Aga Khan University, Department of Pediatrics and Child Health, Karachi, Pakistan.
9
Sanofi Pasteur, Swiftwater, PA, USA.
10
Kelly Government Solutions, Contractor to DAIDS/NIAID/NIH, Rockville, MD, USA.
11
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA.
12
Global Healthcare Consulting, Delhi, India; Erasmus University Medical Center, Rotterdam, The Netherlands.
13
Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases and Global Health Center, Cincinnati, OH, USA.

KEYWORDS:

Adverse event; Brighton collaboration; Case definition; GAIA; Guidelines; Maternal immunisation; Small for gestational age

PMID:
29150057
PMCID:
PMC5710996
DOI:
10.1016/j.vaccine.2017.01.040
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center